++
For further information, see CMDT Part 29-04: Obesity
+++
Essentials of Diagnosis
++
Disorder of energy homeostasis; body mass index (BMI) ≥ 30
Central obesity (abdomen and flank) is a greater health risk than excess weight in the lower body (buttocks and thighs)
Over 200 health conditions are more prevalent in patients with obesity; associated comorbidities include
+++
General Considerations
++
Quantitative evaluation involves determination of BMI
BMI accurately reflects the presence of excess adipose tissue but does not reflect body composition; it is calculated by dividing measured body weight in kilograms by height in meters squared
Normal: BMI = 18.5–24.9
Overweight: BMI = 25–29.9
Class I obesity: BMI = 30–34.9
Class II obesity: BMI = 35–39.9
Class III (extreme) obesity: BMI ≥ 40
Increased abdominal circumference (> 102 cm in men and > 88 cm in women) or high waist/hip ratios (> 1.0 in men and > 0.85 in women) have a greater risk of weight-related comorbid conditions and early death than patients with the same BMI and lower ratios
Central obesity (excess adipose tissue around the waist and flank) is a greater health hazard than lower body obesity (adipose tissue in the thighs and buttocks)
Visceral fat within the abdominal cavity is more hazardous to health than subcutaneous fat around the abdomen
++
Over 40% of Americans have obesity
Both genetic and environmental factors contribute to the development of obesity
Twin studies demonstrate that genetics account for 40–90% of variation in BMI
Only a small percentage of human obesity is thought to be due to single gene mutations
Most obesity develops from the interactions of multiple genes, environmental factors, and behaviors
The rapid increase in obesity in the last several decades points to major roles for environmental and behavioral factors in its development
++
++
++
Medications approved for weight management should be viewed as additions to diet and exercise for patients who have been unsuccessful with lifestyle changes alone
Can be considered in patients with a BMI ≥ 30 or a BMI ≥ 27 plus weight-related comorbidities
The ...